Form 4: Surmodics Executive Sells Shares to Cover Tax Obligations

Surmodics SVP of HR, Joseph J. Stich, disposed of 1,655 shares of common stock to cover tax obligations.

Summary

• Joseph J. Stich, a Senior Vice President at Surmodics, sold 1,655 shares of common stock on November 30, 2024.
• The sale was executed at a price of $39.45 per share.
• This transaction was to cover tax obligations related to stock awards.
• Following the transaction, Stich directly owns 62,665 shares of Surmodics common stock.
• The report also notes that 349 shares were acquired through the Employee Stock Purchase Plan on August 31, 2024.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction and does not indicate any positive or negative sentiment. It is a standard regulatory filing.

Industry Context

This is a routine filing related to executive stock transactions and is common for publicly traded companies. It does not indicate any specific trend or issue within the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical executive stock sales for tax purposes.
• Similar filings are regularly seen across the medical device industry, with executives often selling shares to cover tax obligations related to stock-based compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive.

Key Dates

Keywords

Surmodics, stock sale, insider trading, Form 4, executive compensation, employee stock purchase plan, SRDX